Eli Lilly & Company (Lilly) is a global pharmaceutical company, developing therapies for various diseases.
Lilly was first company to mass-produce penicillin and was also, one of the first to produce human insulin using rDNA technology. In 2019 Lilly created Loxo Oncology at Lilly, with the goal of rapidly delivering impactful new medicines for people with cancer.
[stock_market_widget type=”comparison” template=”basic2″ color=”#5679FF” assets=”LLY,RHHBY,BMY,NVS” fields=”name,change_abs,change_pct,volume,dividend_yield,eps,pe_ratio,shares_outstanding,market_cap,chart” links=”{‘LLY’:{},’BMY’:{},’NVS’:{},’RHHBY’:{}}” api=”yf” chart_range=”1y” chart_interval=”1d”]
Stock Performance of Eli Lilly & Company Vs Global Peers
Page 3 of 3
